Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225933 · ClinicalTrials.gov registry record
A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System
A clinical trial of Kidney Stone and Kidney Stones, sponsored by Calyxo.
- Active
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT07225933: Active study of Kidney Stone and Kidney Stones, sponsored by Calyxo.
NCT07225933 is a study of Kidney Stone and Kidney Stones that is active but no longer recruiting, run by Calyxo. The registered enrollment target is 3,000 participants, above the 86-participant average among 28 other Kidney Stone trials with a reported enrollment target (3388% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225933, a study of Kidney Stone and Kidney Stones, is active but no longer recruiting, sponsored by Calyxo.
- ACTIVE NOT RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective, multi-center collaboration to assess real-world outcomes of a novel steerable aspiration system, the CVAC® System ("CVAC"), and flexible and navigable suction ureteral access sheath (FANS) for the treatment of urinary stones.
Primary Outcome
Completed by reviewing any available standard of care post-procedure imaging
Conditions Studied
Interventions
- DEVICE CVAC® SYSTEM
- DEVICE FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS)
Study Locations (1)
California
- University of California San Diego (UCSD) - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2026-09 |
What the registry record for NCT07225933 still lists
NCT07225933 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 86-participant average among 28 other Kidney Stone trials with a reported enrollment target (3388% higher).
The record links to 3 conditions, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which CVAC® SYSTEM is the first listed.
NCT07225933 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07225933 about?
NCT07225933 is a clinical study titled "A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System". This is a retrospective, multi-center collaboration to assess real-world outcomes of a novel steerable aspiration system, the CVAC® System ("CVAC"), and flexible and navigable suction ureteral access sheath (FANS) for the treatment of urinary stones.
What is the current status of trial NCT07225933?
This trial is currently active not recruiting. The enrollment target is 3,000 participants. The study started on 2024-02-01. Estimated completion is 2026-09.
What conditions does trial NCT07225933 study?
This clinical trial studies the following conditions: Kidney Stone, Kidney Stones, Urolithiasis.
What interventions are being tested in trial NCT07225933?
The interventions under investigation include: CVAC® SYSTEM (DEVICE), FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS) (DEVICE).
Who is sponsoring clinical trial NCT07225933?
This trial is sponsored by Calyxo, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225933 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07225933's enrollment target sits among peer trials
3,000 1st of 28 higher than 28 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI